Related references
Note: Only part of the references are listed.Dose translation from animal to human studies revisited
Shannon Reagan-Shaw et al.
FASEB JOURNAL (2008)
Ajulemic acid, a synthetic cannabinoid acid, induces an antiinflammatory profile of eicosanoids in human synovial cells
Judith A. Stebulis et al.
LIFE SCIENCES (2008)
Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid
Jennifer Parker et al.
RHEUMATOLOGY INTERNATIONAL (2008)
Resolution of inflammation: state of the art, definitions and terms
Charles N. Serhan et al.
FASEB JOURNAL (2007)
Suppression of fibroblast metalloproteinases by ajulemic acid, a nonpsychoactive cannabinoid acid
David R. Johnson et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Chronic inflammation: a failure of resolution?
Toby Lawrence et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2007)
Properties of the Group IV phospholipase A2 family
Moumita Ghosh et al.
PROGRESS IN LIPID RESEARCH (2006)
Lipoxins and new lipid mediators in the resolution of inflammation
Jan M. Schwab et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Anti-inflammatory circuitry: Lipoxin, aspirin-triggered lipoxins and their receptor ALX
N Chiang et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2005)
Ajulemic acid (IP-751): Synthesis, proof of principle, toxicity studies, and clinical trials
S Burstein
AAPS JOURNAL (2005)
Modulation of interferon-induced genes by lipoxin analogue in anti-glomerular basement membrane nephritis
T Ohse et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain - A randomized controlled trial
M Karst et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Suppression of human monocyte interleukin-1β production by ajulemic acid, a nonpsychoactive cannabinoid
RB Zurier et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Prospects for cannabinoids as anti-inflammatory agents
RB Zurier
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
The cyclopentenone prostaglandin 15-deoxy-Δ12,14-prostaglandin J2 attenuates the development of acute and chronic inflammation
S Cuzzocrea et al.
MOLECULAR PHARMACOLOGY (2002)
Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways
CN Serhan et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Ajulemic acid (CT3): A potent analog of the acid metabolites of THC
SH Burstein
CURRENT PHARMACEUTICAL DESIGN (2000)
Share Paper
